Clinical trial
A Prospective, Multi-center, Post-marketing Observational Study to Evaluate the Effectiveness and Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic Patients
NCT01226095 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Post-marketing Observational Study to Evaluate the Effectiveness and Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic Patients
- Lead sponsor
- Abbott
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- November 30, 2010
- Enrollment
- 519 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
morning stiffness, osteoarthritis, pain